SCHEMBL21776071

SCHEMBL21776071

COC(=O)/C(C#N)=C/c1ccc(-c2cc3c(s2)-c2c(F)c4c(c(F)c2C3(c2ccc(C)cc2)c2ccc(C)cc2)-c2sc(-c3ccc(/C=C(\C#N)C(=O)OC)c5nsnc35)cc2C4(c2ccc(C)cc2)c2ccc(C)cc2)c2nsnc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
SLC16A1 P53985 2/20 0.32
ABCB1 P08183 1/20 0.32
LMNA P02545 3/20 0.31
HPGD P15428 1/20 0.31
KDM4E B2RXH2 2/20 0.31
TNNI3 P19429 1/20 0.31
CRHBP P24387 1/20 0.31
TNNT2 P45379 1/20 0.31
KLK7 P49862 1/20 0.31
TNNC1 P63316 1/20 0.31
CRHR2 Q13324 1/20 0.31
POLB P06746 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21776019 0.88 ALDH1A1 (0.33) ALDH1A1MAPTKMT2AMEN1ADORA2A
SCHEMBL21776016 0.87 MAPT (0.31) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL20042531 0.76 MAPT (0.32) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL21776013 0.75 KDM4E (0.32) MAPTKMT2AMEN1KDM4E
SCHEMBL20042533 0.72 KDM4E (0.32) MAPTKMT2AMEN1KDM4E
SCHEMBL20042480 0.72 KDM4E (0.30) MAPTKMT2AMEN1KDM4E
SCHEMBL19917216 0.72
SCHEMBL19917220 0.70
SCHEMBL20043929 0.70
SCHEMBL20040165 0.70 MEN1 (0.32) ALDH1A1MAPTKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200066998-A1 ORGANIC SEMICONDUCTING COMPONDS MERCK PATENT GMBH (DE) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200066998-A1 ORGANIC SEMICONDUCTING COMPONDS EED, OCIAD2, OCIAD1 ALDH1A1 2698/4885MAPT 36/4885KMT2A 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.